Thursday, Oct. 19, 2017
Bill C-393 seeks to amend Canada's Access to Medicines Regime passed in 2004 that allows generic drug manufacturers to be granted a 'compulsory licence' to manufacture and export a generic version of a brand-name drug to a developing country facing an eme
Sent to you every weekday morning. SIGN UP.
© 2017 Hill Times Publishing |
Contact Us |
Work with Us |